Akin to adult stem cells, precursor exhausted T cells are hierarchically organized, with long-lived CD62L+ stem-like T cells at the apex of the system. The transcription factor c-Myb controls the formation, maintenance and therapeutic function of these cells, with important implications for their clinical utilization.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gattinoni, L. et al. Nat. Med. 17, 1290–1297 (2011).
Utzschneider, D. T. et al. Immunity 45, 415–427 (2016).
Im, S. J. et al. Nature 537, 417–421 (2016).
Tsui, C. et al. Nature https://doi.org/10.1038/s41586-022-05105-1 (2022).
Yao, C. et al. Nat. Immunol. 20, 890–901 (2019).
Dykstra, B. et al. Cell Stem Cell 1, 218–229 (2007).
Johnnidis, J. B. et al. Sci. Immunol. 6, eabe3702 (2021).
Gautam, S. et al. Nat. Immunol. 20, 337–349 (2019).
Pais Ferreira, D. et al. Immunity 53, 985–1000 e1011 (2020).
Bresser, K. et al. Nat. Immunol. 23, 791–801 (2022).
Galletti, G. et al. Nat. Immunol. 21, 1552–1562 (2020).
Chen, Z. et al. Cell Rep. 20, 2584–2597 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
L.G. is an inventor on a patent that describes methods for generating and isolating TSCM cells and on a patent that describes the use of c-Myb to enhance T cell therapy efficacy. L.G. has consulting agreements with Lyell Immunopharma, Advaxis Immunotherapies and Instil Bio, is on the scientific advisory boards of Poseida Therapeutics and Kiromic, and is a stockholder of Poseida Therapeutics. C.H. declares no competing interests.
Rights and permissions
About this article
Cite this article
Heuser, C., Gattinoni, L. c-Myb redefines the hierarchy of stem-like T cells. Nat Immunol 23, 1405–1407 (2022). https://doi.org/10.1038/s41590-022-01319-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-022-01319-7
